Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of αCaMKII inhibitory phosphorylation-Reference-Cited by-同舟云学术

Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of αCaMKII inhibitory phosphorylation

Published:2007-01-28 Issue:3 Volume:10 Page:280-282
ISSN:1097-6256
Container-title:Nature Neuroscience
language:en
Short-container-title:Nat Neurosci

Author:

van Woerden Geeske M,Harris Karen D,Hojjati Mohammad Reza,Gustin Richard M,Qiu Shenfeng,de Avila Freire Rogerio,Jiang Yong-hui,Elgersma Ype,Weeber Edwin J

Publisher

Springer Science and Business Media LLC

Subject

General Neuroscience

Link

http://www.nature.com/articles/nn1845.pdf

Reference15 articles.

1. Knoll, J.H. et al. Am. J. Med. Genet. 32, 285–290 (1989).

2. Sutcliffe, J.S. et al. Genome Res. 7, 368–377 (1997).

3. Matsuura, T. et al. Nat. Genet. 15, 74–77 (1997).

4. Kishino, T., Lalande, M. & Wagstaff, J. Nat. Genet. 15, 70–73 (1997).

5. Albrecht, U. et al. Nat. Genet. 17, 75–78 (1997).

Cited by 243 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Clinical and Genetic Landscape of Angelman Syndrome: Patient-Reported Insights from an Italian Registry;Journal of Clinical Medicine;2024-06-16

2. Peptidomimetic inhibitors targeting TrkB/PSD-95 signaling improves cognition and seizure outcomes in an Angelman Syndrome mouse model;2024-06-08

3. Insights into the structure and function of the hippocampus: implications for the pathophysiology and treatment of autism spectrum disorder;Frontiers in Psychiatry;2024-04-23

4. Outcome measures in Angelman syndrome;Journal of Neurodevelopmental Disorders;2024-03-01

5. Neural hyperexcitability in Angelman syndrome: Genetic factors and pharmacologic treatment approaches;Epilepsy Research;2024-02